HomeAMBU-B • CPH
add
Ambu A/S
Previous close
kr 110.85
Day range
kr 111.55 - kr 114.65
Year range
kr 88.02 - kr 154.60
Market cap
26.78B DKK
Avg Volume
473.25K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Market news
Financials
Income Statement
Revenue
Net income
| (DKK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.39B | 10.17% |
Operating expense | 670.00M | 8.41% |
Net income | -135.00M | -268.75% |
Net profit margin | -9.73 | -253.23% |
Earnings per share | 0.43 | 35.57% |
EBITDA | 242.00M | 78.60% |
Effective tax rate | 25.41% | — |
Balance Sheet
Total assets
Total liabilities
| (DKK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 615.00M | 291.72% |
Total assets | 7.15B | 4.30% |
Total liabilities | 1.56B | 6.41% |
Total equity | 5.59B | — |
Shares outstanding | 266.39M | — |
Price to book | 5.28 | — |
Return on assets | 5.09% | — |
Return on capital | 5.87% | — |
Cash Flow
Net change in cash
| (DKK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -135.00M | -268.75% |
Cash from operations | 193.00M | -29.30% |
Cash from investing | -95.00M | -11.76% |
Cash from financing | -18.00M | 89.71% |
Net change in cash | 81.00M | 523.08% |
Free cash flow | 100.88M | -2.65% |
About
Ambu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services.
It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse.
The largest business areas are anesthesia, cardiology, neurology, pulmonology, urology and gastroenterology. The company's most important products are devices for artificial ventilation, single-use endoscopes and single-use electrodes for ECG tests and neurophysiological mappings. Wikipedia
Founded
1937
Website
Employees
5,196
